Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Vincristine Sulfate Liposome Or Vincristine Sulfate For Injection Combined Chemotherapy as Initial Induction Regimen In Adults Acute Lymphoblastic Leukemia

NCT02072785 is registered in ClinicalTrials.gov with Nanjing Luye Sike Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT02072785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02072785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Vincristine Sulfate Liposome Or Vincristine Sulfate For Injection Combined Chemotherapy as Initial Induction Regimen In Adults Acute Lymphoblastic Leukemia
Lead sponsor
Nanjing Luye Sike Pharmaceutical Co., Ltd.
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2013
Completion date
February 28, 2017
Enrollment
480 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult acute lymphoblastic leukemia